申请人:TANABE SEIYAKU CO., LTD.
公开号:EP1582521A1
公开(公告)日:2005-10-05
The present invention provides a condensed furan compound of the formula (I):
wherein Ring X is benzene, pyridine, or the like; Y is an optionally substituted amino, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted saturated heterocyclic group, an optionally substituted unsaturated heterocyclic group; A is a single bond, lower alkylene, lower alkenylidene, lower alkenylene or an oxygen atom; R3 is hydrogen or the like; and , R4 is hydrogen, or the like, or pharmaceutically acceptable salts thereof, which is useful as a medicament, particularly, as an activated blood coagulation factor X inhibitor.
本发明提供了一种式(I)的缩合呋喃化合物:
其中,环 X 是苯、吡啶或类似物;Y 是任选取代的氨基、任选取代的环烷基、任选取代的芳基、任选取代的饱和杂环基团、任选取代的不饱和杂环基团;A 是单键、低级亚烷基、低级亚烯基、低级亚烯基或氧原子;R3 是氢或类似物;以及 ,R4 是氢或类似物,或其药学上可接受的盐,可用作药物,特别是用作活化的凝血因子 X 抑制剂。